zoladex造句
- Zoladex sales rose by 21 percent, while Nolvadex sales rose 1 percent.
- AstraZeneca confirmed Tuesday night that it is the only company that sells Zoladex.
- The company previously disclosed that investigators were looking at its marketing of Zoladex.
- Zoladex is an injectable drug that is often administered in a doctor's office.
- Any Zoladex sample provided to customers clearly states that the product is not for retail sale.
- Salomon Brothers forecast Zoladex will post a 29 percent sales rise to 337 million pounds in 1996.
- But the treatment also involved hormone therapy, a Zoladex injection every three months for a year.
- "But I have been off Zoladex for over a year, " he said.
- The company launched four products in China in 1994, including Diprivan, Zoladex, Tenormin and Zestil.
- Zeneca makes Nolvadex and Arimidex to treat breast cancer, and Zoladex and Casodex to treat prostate cancer.
- It's difficult to see zoladex in a sentence. 用zoladex造句挺难的
- The case is significant because it is the first to involve Zoladex, a drug sold by AstraZeneca.
- Zeneca makes the best selling-heart drugs Zestril and Nolvadex and anti-cancer drugs Zoladex and Nolvadex.
- Zeneca's mainstay has been cardiovascular drugs such as Zestril and cancer drugs such as Nolvadex and Zoladex.
- For the last decade, TAP has been in a marketing battle with AstraZeneca Pharmaceuticals, which makes Zoladex.
- Its Nolvadex for breast cancer and Zoladex for prostate cancer had combined worldwide sales last year of $ 775 million.
- Researchers from throughout Europe treated 415 patients with radiation alone or radiation plus Zoladex, and followed their medical progress.
- Doctors know testosterone fuels prostate cancer growth, and currently prescribe the drugs Leupron or Zoladex to inhibit its production.
- Sales of cancer drugs jumped 9 percent to $ 455 million, with Zoladex posting an increase of 19 percent.
- Zoladex was approved by the U . S . Food and Drug Administration in 1989 for treatment of prostate cancer.
- Zoladex had worldwide sales of dlrs 738 million in 2001, more than any other cancer drug in AstraZeneca's portfolio.